HAPLN1 and Miyoshi myopathy: These results support the hypothesis that selinexor can block HAPLN1-PTR1-induced IκBα degradation via its nuclear sequestration causing inhibition of IκBα-associated NF-κB activation to overcome the survival effects induced by HAPLN1-PTR1 in MM cells.